Suppr超能文献

基于多PLD的动脉自旋标记脑灌注ASPECTS在急性缺血性卒中中的预后价值。

Prognostic value of multi-PLD ASL-based cerebral perfusion ASPECTS in acute ischemic stroke.

作者信息

Li Qingqing, Jiang Chaojun, Qian Linqing, Yang Jing, Mu Tianchi, Dong Congsong, Wang Shu, Wang Zhenyu, Liu Hengheng, Dong Yijun, Dai Zhenyu, Chen Fei

机构信息

Department of Radiology, Suzhou Wuzhong People's Hospital, Suzhou, Jiangsu, China.

Department of Radiology, Affiliated Hospital 6 of Nantong University, Yancheng, Jiangsu, China.

出版信息

Front Neurol. 2024 Oct 9;15:1476937. doi: 10.3389/fneur.2024.1476937. eCollection 2024.

Abstract

INTRODUCTION

We aimed to verify the application value of the Alberta Stroke Program Early CT Score (ASPECTS) based on multiple post-labeling delay (multi-PLD) arterial spin labeling (ASL) for outcome assessment in acute ischemic stroke (AIS) patients.

METHOD

The endpoint was modified Rankin scale score at 90 days (90-day mRS). Patients were divided into the good outcome (0-2) and poor outcome (3-6) groups. The independent samples -test, Mann-Whitney -test, and χ-test were used to compare clinical and imaging parameters between groups. We used partial correlation analysis to evaluate the relationships between ASPECTS and outcomes. Multivariate logistic regression analysis was used to examine potential independent prognostic indicators. The receiver operating characteristic (ROC) curve analysis was used to evaluate the performance of the independent prognostic indicators in predicting outcomes.

RESULTS

Fifty-five AIS patients were included. The good outcome group had a lower baseline National Institutes of Health Stroke Scale (NIHSS; = -3.413, < 0.001) and infarct core volume (ICV; = -3.114, = 0.002) as well as higher cerebral blood flow (CBF)-ASPECTS ( = -3.835, < 0.001) and cerebral blood volume (CBV)-ASPECTS ( = -4.099, < 0.001). Higher CBF-ASPECTS ( = -0.459, = 0.001), and CBV-ASPECTS ( = -0.502, < 0.001) were associated with a lower 90-day mRS. The baseline NIHSS, CBF-ASPECTS, and CBV-ASPECTS were identified as independent prognostic indicators. The AUCs of the baseline NIHSS, CBF-ASPECTS, and CBV-ASPECTS were 83.3, 87.4, and 89.9%, respectively. Combining NIHSS with CBF-ASPECTS and CBV-ASPECTS, the AUC significantly improved to 96.3%. The combined three factors showed a significant difference compared to the baseline NIHSS ( = 2.039, = 0.041) and CBF-ASPECTS ( = 2.099, = 0.036), but no difference with CBV-ASPECTS ( = 1.176, = 0.239).

CONCLUSIONS

The ASPECTS based on multi-PLD ASL is a valuable tool for identifying independent prognostic indicators and assessing clinical outcomes in AIS patients. The baseline NIHSS, combined with CBF-ASPECTS and CBV-ASPECTS, enhances the predictive efficacy of clinical outcomes in AIS patients. The CBV-ASPECTS alone can offer comparable predictive efficacy to the combination.

摘要

引言

我们旨在验证基于多次标记后延迟(multi-PLD)动脉自旋标记(ASL)的阿尔伯塔卒中项目早期CT评分(ASPECTS)在急性缺血性卒中(AIS)患者结局评估中的应用价值。

方法

终点指标为90天时的改良Rankin量表评分(90天mRS)。患者被分为良好结局(0 - 2)组和不良结局(3 - 6)组。采用独立样本t检验、Mann-Whitney U检验和χ²检验比较两组间的临床和影像学参数。我们使用偏相关分析来评估ASPECTS与结局之间的关系。采用多因素逻辑回归分析来检验潜在的独立预后指标。采用受试者工作特征(ROC)曲线分析来评估独立预后指标在预测结局方面的性能。

结果

纳入55例AIS患者。良好结局组的基线美国国立卫生研究院卒中量表(NIHSS;t = -3.413,P < 0.001)和梗死核心体积(ICV;t = -3.114,P = 0.002)较低,以及脑血流量(CBF)-ASPECTS(t = -3.835,P < 0.001)和脑血容量(CBV)-ASPECTS(t = -4.099,P < 0.001)较高。较高的CBF-ASPECTS(r = -0.459,P = 0.001)和CBV-ASPECTS(r = -0.502,P < 0.001)与较低的90天mRS相关。基线NIHSS、CBF-ASPECTS和CBV-ASPECTS被确定为独立预后指标。基线NIHSS、CBF-ASPECTS和CBV-ASPECTS的曲线下面积(AUC)分别为83.3%、87.4%和89.9%。将NIHSS与CBF-ASPECTS和CBV-ASPECTS相结合,AUC显著提高至96.3%。联合三个因素与基线NIHSS(Z = 2.039,P = 0.041)和CBF-ASPECTS(Z = 2.099,P = 0.036)相比有显著差异,但与CBV-ASPECTS(Z = 1.176,P = 0.239)无差异。

结论

基于multi-PLD ASL的ASPECTS是识别AIS患者独立预后指标和评估临床结局的有价值工具。基线NIHSS与CBF-ASPECTS和CBV-ASPECTS相结合,可提高AIS患者临床结局的预测效能。单独的CBV-ASPECTS可提供与联合指标相当的预测效能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f7b/11496281/76bda56d79f6/fneur-15-1476937-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验